Exabis Library
Welcome to the e-CCO Library!
OP001: Gut barrier dysfunction: a primary defect in twins with Crohn’s disease predominantly caused by genetic predisposition
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP001: Whole genome sequencing and imputation in inflammatory bowel disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s disease cohort shows a quiescent disease course for a substantial proportion of the population
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP002: Epigenetic biomarkers to detect ulcerative colitis-associated neoplasia: results from phase I of the ENDCAP-C study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP002: Histopathological response and remission after dual topical application of the Toll-like receptor 9 agonist DIMS0150 in patients with moderate-to-severe ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP003: Increased risk of acute arterial events in young patients with severely active inflammatory bowel disease: a nationwide French cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP003: Predicting short and medium-term efficacy of the biosimilar infliximab: trough levels/do anti-drug antibody’s or clinical/biochemical markers play a more important role?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP004: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP005: A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-tumour necrosis factor serum levels in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP005: Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP005: The PROSIT cohort of infliximab biosimilar in IBD: a prolonged follow-up on the efficacy and safety across Italy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP006: Autophagy regulates dendritic cell migration through Rac1: implications for thiopurine therapy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP006: Correlation of durability of response, serum trough concentrations and outcome parameters: long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP006: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP007: α4β7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP007: Comprehensive epigenome-wide DNA methylation profiling in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM